BioSpace News Archive

The Canadian Life and Health Insurance industry is reviewing the federal Standing Committee on Health’s report Pharmacare Now: Prescription Medicine Coverage for all Canadians, and the accompanying Dissenting and Supplementary Opinions presented to the House of Commons today.

GlaxoSmithKline plc and Innoviva, Inc. announced the publication in the New England Journal of Medicine (NEJM) of the landmark IMPACT study, one of the biggest ever conducted in patients with chronic obstructive pulmonary disease (COPD) with a history of exacerbation.

Montefiore’s short film Corazón will be making its world premiere during the Tribeca Film Festival on Friday, April 20, at 7:00 p.m. at the iPic Theaters at Fulton Market.

Today, the Senate Committee on Health held a hearing to discuss legislation introduced by Sen. Scott Wiener, SB 1464, which aims to increase access to critically-needed oral healthcare for children and adults covered by Denti-Cal with chronic medical, mental, behavioral, or developmental conditions and disabilities.

Performance and Age Management Medicine is pleased to announce they now offer GAINSWave!

WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced the opening of its expanded Laboratory Testing Division (LTD) facility in New Jersey.

The American Lung Association’s State of the Air 2018 report shows that once again California has some of the worst air quality in the nation.

Shionogi & Co., Ltd. announced that the company will give 13 presentations on investigational agents at the upcoming European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in Madrid, Spain, April 21-24, 2018.

According to a research by Oristep Consulting, the global medical cannabis market in 2016 was USD 12.67 billion and will reach USD 33.41 billion by 2022 at a CAGR of 17.53% during the forecasted period.

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, announced preclinical data on XmAb24306, an IL15/IL15-receptor alpha complex fused to a bispecific XmAb Fc domain (IL15/IL15Rα-Fc) for the treatment of multiple oncology indications